COMMUNIQUÉS West-GlobeNewswire

ReWalk Robotics to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6th
23/08/2018
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Aug. 23, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer, and Ori Gon, [...]
AssistRx Supports Company Growth with Appointment of Executive Vice President, Data Solutions
23/08/2018
Richard Prest, life sciences industry leader with extensive background in growing technology organizations, joins AssistRx to further develop the company’s data solutions ORLANDO, Fla., Aug. 23, 2018 (GLOBE NEWSWIRE [...]
Scythian Biosciences Shifts Focus Exclusively to The United States as National Acceptance of Medical Cannabis Surges
23/08/2018
US Strategy Led by Imminent Closing of Florida Acquisition of Exclusive Medical Cannabis License Scythian Slated for Corp Name Change to Sol Investments Corp. Following Upcoming Special Meeting TORONTO, Aug. 23, 2018 ( [...]
Assure Holdings to Resume Trading
23/08/2018
DENVER, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, is pleased to announce that it has received a [...]
Avinger Completes Enrollment in SCAN Clinical Study
23/08/2018
Post-Market Study Compares Pantheris OCT Imaging with IVUS for Diagnostic Imaging in Peripheral Arteries REDWOOD CITY, Calif., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR), a leading developer of [...]
Intellia Therapeutics to Host Educational Briefing Webinar on Interference Proceedings Relating to CRISPR/Cas9 Genome Editing Technology Patents
23/08/2018
CAMBRIDGE, Mass., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology, will host an [...]
Terra Tech Subsidiary, Edible Garden, Selected to Supply Organic Leafy Greens to Leading National Grocery Chains
23/08/2018
IRVINE, Calif., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC) (“Terra Tech” or the “Company”) today announced that its subsidiary, Edible Garden, a nationwide provider of fresh, locally-grown herbs [...]
BrainStorm Cell Therapeutics Announces Successful Interim Safety Analysis in Phase 3 Trial of NurOwn® Therapy for ALS
23/08/2018
NEW YORK, and PETACH TIKVA, Israel, Aug. 23, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc., (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced [...]
Forward Pharma to Participate in the LSX Nordic Congress
23/08/2018
COPENHAGEN, Denmark, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will participate in the LSX [...]
Vical to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
23/08/2018
SAN DIEGO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on Wednesday, September 5, [...]
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
23/08/2018
WALTHAM, Mass., Aug. 23, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company management will participate in the following investor conferences: B. Riley FBR Healthcare [...]
New Insights on Disease Burden for Hypertrophic Cardiomyopathy Patients Published in Circulation
23/08/2018
HCM Patients at Greater Risks of Atrial Fibrillation, Heart Failure and Increased Mortality Younger Age of Diagnosis and Genetic Status Associated with Higher Rates of Long-term Complications and Early Death SOUTH SAN [...]
Krystal Biotechs’ KB105 Receives Rare Pediatric Disease Designation from the FDA to Treat Patients with TGM-1-deficient Autosomal Recessive Congenital Ichthyosis
23/08/2018
KB105 is Krystal’s second "off-the-shelf" topical gene therapy candidate to receive Rare Pediatric Disease Designation for treating debilitating skin diseases PITTSBURGH, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Krystal [...]
GBT Expands Sickle Cell Disease Pipeline with Worldwide Licensing Agreement for Inclacumab for the Treatment of Vaso-occlusive Crisis
23/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) announced today that it has entered into an exclusive worldwide licensing agreement with F. Hoffmann-La [...]
Eidos Therapeutics Announces Publication of AG10 Molecular Design in Journal of Medicinal Chemistry
23/08/2018
SAN FRANCISCO, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) today announced publication of the design and preclinical characterization of its lead product candidate, AG10, in the [...]
Tetra Bio-Pharma Targets Rare Cancers in the United States
23/08/2018
Tetra submits multiple cannabinoid applications to the FDA OTTAWA, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“ Tetra ” or “ TBP ”), today announced the submission of multiple applications for Orphan Drug [...]
CTD Holdings’ Trappsol® Cyclo™ Featured in Television Program on Niemann-Pick Disease Type C
23/08/2018
ALACHUA, Fla., Aug. 23, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, [...]
Inovalon to Present at the Citi 2018 Global Technology Conference
23/08/2018
BOWIE, Md., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, MD, [...]
Novelion Therapeutics Announces Next Phase of Operational Improvements
23/08/2018
Once fully implemented, plans expected to reduce annual costs by approximately $35 million VANCOUVER, British Columbia, Aug. 23, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical [...]

Pages